vs
美泰（MAT）与福泰制药（VRTX）财务数据对比。点击上方公司名可切换其他公司
福泰制药的季度营收约是美泰的3.7倍（$3.2B vs $862.2M），福泰制药净利率更高（37.3% vs 7.1%，领先30.3%），福泰制药同比增速更快（9.5% vs 4.3%），福泰制药自由现金流更多（$348.6M vs $-88.1M），过去两年福泰制药的营收复合增速更高（8.9% vs -10.6%）
美泰是美国知名玩具及娱乐企业，旗下影视制作部门美泰影业运营时间为2018年9月6日至2025年6月2日。其前身为2013年10月16日成立的美泰Playground Productions，更早可追溯至美泰娱乐、美泰工作室等集团原有娱乐业务品牌。
福泰制药是总部位于美国马萨诸塞州波士顿的生物制药企业，是全球首批明确采用理性药物设计策略、而非组合化学方法开发药物的生物技术公司之一。除波士顿总部外，公司还在加州圣迭戈、英国牛津郡米尔顿公园设有三处研发中心。
MAT vs VRTX — 直观对比
营收规模更大
VRTX
是对方的3.7倍
$862.2M
营收增速更快
VRTX
高出5.2%
4.3%
净利率更高
VRTX
高出30.3%
7.1%
自由现金流更多
VRTX
多$436.7M
$-88.1M
两年增速更快
VRTX
近两年复合增速
-10.6%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $862.2M | $3.2B |
| 净利润 | $61.0M | $1.2B |
| 毛利率 | 44.9% | 85.4% |
| 营业利润率 | — | 37.8% |
| 净利率 | 7.1% | 37.3% |
| 营收同比 | 4.3% | 9.5% |
| 净利润同比 | 251.4% | 30.5% |
| 每股收益（稀释后） | $0.20 | $4.64 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MATVRTX
| Q1 26 | $862.2M | — | ||
| Q4 25 | $1.8B | $3.2B | ||
| Q3 25 | $1.7B | $3.1B | ||
| Q2 25 | $1.0B | $3.0B | ||
| Q1 25 | $826.6M | $2.8B | ||
| Q4 24 | $1.6B | $2.9B | ||
| Q3 24 | $1.8B | $2.8B | ||
| Q2 24 | $1.1B | $2.6B |
净利润MATVRTX
| Q1 26 | $61.0M | — | ||
| Q4 25 | $106.2M | $1.2B | ||
| Q3 25 | $278.4M | $1.1B | ||
| Q2 25 | $53.4M | $1.0B | ||
| Q1 25 | $-40.3M | $646.3M | ||
| Q4 24 | $140.9M | $913.0M | ||
| Q3 24 | $372.4M | $1.0B | ||
| Q2 24 | $56.9M | $-3.6B |
毛利率MATVRTX
| Q1 26 | 44.9% | — | ||
| Q4 25 | 45.9% | 85.4% | ||
| Q3 25 | 50.0% | 86.5% | ||
| Q2 25 | 50.9% | 86.3% | ||
| Q1 25 | 49.4% | 86.9% | ||
| Q4 24 | 50.7% | 85.5% | ||
| Q3 24 | 53.1% | 85.8% | ||
| Q2 24 | 49.2% | 85.9% |
营业利润率MATVRTX
| Q1 26 | — | — | ||
| Q4 25 | 8.0% | 37.8% | ||
| Q3 25 | 21.9% | 38.6% | ||
| Q2 25 | 7.7% | 38.8% | ||
| Q1 25 | -6.4% | 22.7% | ||
| Q4 24 | 9.6% | 35.2% | ||
| Q3 24 | 26.5% | 40.3% | ||
| Q2 24 | 7.7% | -132.9% |
净利率MATVRTX
| Q1 26 | 7.1% | — | ||
| Q4 25 | 6.0% | 37.3% | ||
| Q3 25 | 16.0% | 35.2% | ||
| Q2 25 | 5.2% | 34.8% | ||
| Q1 25 | -4.9% | 23.3% | ||
| Q4 24 | 8.6% | 31.4% | ||
| Q3 24 | 20.2% | 37.7% | ||
| Q2 24 | 5.3% | -135.8% |
每股收益（稀释后）MATVRTX
| Q1 26 | $0.20 | — | ||
| Q4 25 | $0.32 | $4.64 | ||
| Q3 25 | $0.88 | $4.20 | ||
| Q2 25 | $0.16 | $3.99 | ||
| Q1 25 | $-0.12 | $2.49 | ||
| Q4 24 | $0.40 | $3.62 | ||
| Q3 24 | $1.09 | $4.01 | ||
| Q2 24 | $0.17 | $-13.92 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $866.0M | $6.6B |
| 总债务越低越好 | $2.3B | — |
| 股东权益账面价值 | $2.1B | $18.7B |
| 总资产 | $6.3B | $25.6B |
| 负债/权益比越低杠杆越低 | 1.11× | — |
8季度趋势，按日历期对齐
现金及短期投资MATVRTX
| Q1 26 | $866.0M | — | ||
| Q4 25 | $1.2B | $6.6B | ||
| Q3 25 | $691.9M | $6.3B | ||
| Q2 25 | $870.5M | $6.4B | ||
| Q1 25 | $1.2B | $6.2B | ||
| Q4 24 | $1.4B | $6.1B | ||
| Q3 24 | $723.5M | $6.5B | ||
| Q2 24 | $722.4M | $5.8B |
总债务MATVRTX
| Q1 26 | $2.3B | — | ||
| Q4 25 | $2.3B | — | ||
| Q3 25 | $2.3B | — | ||
| Q2 25 | $2.3B | — | ||
| Q1 25 | $2.3B | — | ||
| Q4 24 | $2.3B | — | ||
| Q3 24 | $2.3B | — | ||
| Q2 24 | $2.3B | — |
股东权益MATVRTX
| Q1 26 | $2.1B | — | ||
| Q4 25 | $2.2B | $18.7B | ||
| Q3 25 | $2.3B | $17.3B | ||
| Q2 25 | $2.2B | $17.2B | ||
| Q1 25 | $2.1B | $16.5B | ||
| Q4 24 | $2.3B | $16.4B | ||
| Q3 24 | $2.3B | $15.6B | ||
| Q2 24 | $2.0B | $14.8B |
总资产MATVRTX
| Q1 26 | $6.3B | — | ||
| Q4 25 | $6.6B | $25.6B | ||
| Q3 25 | $6.6B | $24.9B | ||
| Q2 25 | $6.2B | $24.0B | ||
| Q1 25 | $6.2B | $22.9B | ||
| Q4 24 | $6.5B | $22.5B | ||
| Q3 24 | $6.5B | $22.2B | ||
| Q2 24 | $5.9B | $20.1B |
负债/权益比MATVRTX
| Q1 26 | 1.11× | — | ||
| Q4 25 | 1.04× | — | ||
| Q3 25 | 1.03× | — | ||
| Q2 25 | 1.08× | — | ||
| Q1 25 | 1.10× | — | ||
| Q4 24 | 1.03× | — | ||
| Q3 24 | 1.01× | — | ||
| Q2 24 | 1.18× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $498.0M |
| 自由现金流经营现金流 - 资本支出 | $-88.1M | $348.6M |
| 自由现金流率自由现金流/营收 | -10.2% | 10.9% |
| 资本支出强度资本支出/营收 | 7.6% | 4.7% |
| 现金转化率经营现金流/净利润 | — | 0.42× |
| 过去12个月自由现金流最近4个季度 | — | $3.2B |
8季度趋势，按日历期对齐
经营现金流MATVRTX
| Q1 26 | — | — | ||
| Q4 25 | $796.6M | $498.0M | ||
| Q3 25 | $72.0M | $1.2B | ||
| Q2 25 | $-300.1M | $1.1B | ||
| Q1 25 | $24.8M | $818.9M | ||
| Q4 24 | $862.1M | $584.6M | ||
| Q3 24 | $155.8M | $1.4B | ||
| Q2 24 | $-252.9M | $-3.8B |
自由现金流MATVRTX
| Q1 26 | $-88.1M | — | ||
| Q4 25 | — | $348.6M | ||
| Q3 25 | — | $1.1B | ||
| Q2 25 | — | $927.4M | ||
| Q1 25 | — | $778.2M | ||
| Q4 24 | — | $492.0M | ||
| Q3 24 | — | $1.3B | ||
| Q2 24 | — | $-3.8B |
自由现金流率MATVRTX
| Q1 26 | -10.2% | — | ||
| Q4 25 | — | 10.9% | ||
| Q3 25 | — | 37.0% | ||
| Q2 25 | — | 31.3% | ||
| Q1 25 | — | 28.1% | ||
| Q4 24 | — | 16.9% | ||
| Q3 24 | — | 47.0% | ||
| Q2 24 | — | -144.5% |
资本支出强度MATVRTX
| Q1 26 | 7.6% | — | ||
| Q4 25 | — | 4.7% | ||
| Q3 25 | — | 3.3% | ||
| Q2 25 | — | 4.9% | ||
| Q1 25 | — | 1.5% | ||
| Q4 24 | — | 3.2% | ||
| Q3 24 | — | 2.4% | ||
| Q2 24 | — | 2.6% |
现金转化率MATVRTX
| Q1 26 | — | — | ||
| Q4 25 | 7.50× | 0.42× | ||
| Q3 25 | 0.26× | 1.15× | ||
| Q2 25 | -5.62× | 1.04× | ||
| Q1 25 | — | 1.27× | ||
| Q4 24 | 6.12× | 0.64× | ||
| Q3 24 | 0.42× | 1.31× | ||
| Q2 24 | -4.45× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MAT
暂无分部数据
VRTX
| TRIKAFTAKAFTRIO | $2.6B | 81% |
| ALYFTREK | $380.1M | 12% |
| Manufactured Product Other | $237.4M | 7% |
